56 results about "Inflammatory marker" patented technology

A method of treating a human subject which is effected by intermittent inhalation of gaseous nitric oxide at a concentration of at least 160 ppm is disclosed. The method can be utilized for treating a human subject suffering from, or prone to suffer from, a disease or disorder that is manifested in the respiratory tract, or from a disease or disorder that can be treated via the respiratory tract. The disclosed method can be effected while monitoring one or more of on-site and off-site parameters such as vital signs, methemoglobin levels, pulmonary function parameters, blood chemistry and hematological parameters, blood coagulation parameters, inflammatory marker levels, liver and kidney function parameters and vascular endothelial activation parameters, such that no substantial deviation from a baseline in seen in one or more of the monitored parameters.

Disclosed herein are compositions comprising tea derived components which are useful in decreasing elevated blood pressures, lowering LDL and / or lowering inflammatory markers of cardiovascular disease. Specifically exemplified herein are compositions comprising predetermined amounts of L-theanine and EGCG, and methods of using same to improve cardiovascular health.

The present invention provides a composition for down-regulating pro-inflammatory markers. The composition comprises boswellic acid fraction and polysaccharide faction obtained from Boswellia species at specific concentrations showing enhancement in their activity as compared to boswellic acid fraction and the polysaccharide fraction alone. The invention further comprises use of polysaccharide fraction individually or in combination with boswellic acid fraction for inhibition of PGE2.

The invention relates to a traditional Chinese medicine prescription for treating pulmonary diseases, which comprises lapis chloriti, roasted ephedra, almond, schisandra, snakegourd peel and roasted licorice. Experiments prove that the traditional Chinese medicine prescription can obviously improve the pulmonary lesion and inflammatory reaction of a model rat with the chronic obstructive pulmonary disease at the acute exacerbation, so as to obviously reduce the contents of main inflammatory markers in the serum of the model rat, and simultaneously can promote the trachea repair of the model rat so as to prevent the occurrence and development of trachea inflammation. Clinical researches show that the traditional Chinese medicine prescription has a good effect and a high effect taking speed when being used for treating empirical pulmonary diseases, such as accumulation of pathogenic heat in the lung and obstruction of the lung by phlegm; the good effect can be achieved within 3-10 days, and the total effective rate reaches 96.6%; the traditional Chinese medicine prescription especially has good curative effects on chronic intractable pulmonary diseases induced by pathogenic heat and stubborn phlegm; the traditional Chinese medicine prescription does not have toxic or side effects; and the pulmonary diseases can not recur.

The invention relates to a method for detecting inflammatory markers and a kit for detecting inflammatory markers to solve the problems of narrow detection range, low sensitivity, manual operation andhigh requirements on climatic conditions for detecting inflammatory markers in the prior art. The method for detecting inflammatory markers and the kit for detecting inflammatory markers provided bythe invention have wider detection range, higher accuracy and sensitivity, can simultaneously detect SAA, PCT and CRP, and are convenient in operation and stable in detection result.